Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: EUCTR 2010-020956-69. We help you review the study, but cannot decide medical eligibility.
CompletedEUCTR 2010-020956-69
Effekte von Oxytocin bei Patientinnen und Patienten mit Borderline-Persönlichkeitsstörung
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Personality disorders, DepressionDrug
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- 0
- Sponsor
- Universitätsklinikum Freiburg
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Germany
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2010-020956-69
- Official title
- Effekte von Oxytocin bei Patientinnen und Patienten mit Borderline-Persönlichkeitsstörung
Recruitment & locations
CompletedGermany
Registry details
Registry conditions (original wording)
ICD-10 F60.3 Emotionally unstable personality disorder Two types may be distinguished: the impulsive type, characterized by emotional instability and lack of impulse control, and the borderline type, characterized in addition by disturbances in self-image, aims, and internal preferences, by chronic feelings of emptiness, by intense and unstable interpersonal relationships, self-destructive behaviour, including suicide gestures and attempts. Clinical control group: major depression (ICD-10 F33)
Historical country statuses
- Germany — Completed
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Universitätsklinikum Freiburg.
Is this study still recruiting?
The historical registry lists this study as completed.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT01243658
"The Effects of Oxytocin on people with Borderline Personality Disorder"
This study is completed. It focuses on personality disorders and currently lists study information in Germany.
CompletedNCT03039192
Intranasal Esketamine for depression
This study is completed in the United States, in Bulgaria, in Estonia, .... It is testing intranasal Esketamine for depression.
CompletedEUCTR 2020-003469-20
A double blind, randomized, placebo-controlled, adaptive 14-week Phase IIb trial to evaluate the efficacy and safety of vafidemstat in an adult borderline personality disorder (BPD) population (PORTICO)
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.